tiprankstipranks

Thomas Wessel Insider Profile

4 Followers
Thomas Wessel, CMO at Salarius Pharmaceuticals, holds 37.06K shares in Salarius Pharmaceuticals (Ticker: SLRX), holds 36.35K shares in Acorda Therapeutics (Ticker: ACORQ). Most recently, Thomas Wessel Bought ― shares of Salarius Pharmaceuticals on Mar 15, 2016 for an estimated value of 158.84K.
tipranks
Thomas Wessel

Thomas Wessel
Salarius Pharmaceuticals (SLRX)
CMO

Not Ranked
Thomas Wessel has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$95K
94.66%
5.34%
A breakdown of Thomas Wessel's holdings

Insider Roles

Salarius Pharmaceuticals
(SLRX)
CMO
Acorda Therapeutics
(ACORQ)
CMO
Roles that Thomas Wessel holds in companies

Most Profitable Insider Trade

Stock:
Salarius Pharmaceuticals
(SLRX)
Rating:Informative Buy
Date:Mar 15, 2016 - Mar 15, 2017
Return:-55.90%
The most profitable trade made by Thomas Wessel

Thomas Wessel's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Salarius Pharmaceuticals
Mar 15, 2016
CMO
Informative Buy
158.84K
$90.25K
Acorda Therapeutics
Mar 07, 2011
CMO
Uninformative Buy
$5.09K
List of latest transactions for each holding click on a transaction to see Thomas Wessel's performance on stock

Thomas Wessel insider profile FAQ

What is the percentage of profitable transactions made by Thomas Wessel?
The percentage of profitable transactions made by Thomas Wessel is ―.
    What is the average return per transaction made by Thomas Wessel?
    The average return per transaction made by Thomas Wessel is ―.
      What stocks does Thomas Wessel hold?
      Thomas Wessel holds: SLRX, ACORQ stocks.
        What was Thomas Wessel’s latest transaction?
        Thomas Wessel latest transaction was an Informative Buy of $158.84K.
          What was Thomas Wessel's most profitable transaction?
          Thomas Wessel’s most profitable transaction was an Informative Buy of SLRX stock on March 15, 2016. The return on the trade was -55.90%.
            What is Thomas Wessel's role in Salarius Pharmaceuticals?
            Thomas Wessel's role in Salarius Pharmaceuticals is CMO.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.